Comprehensive genetic variant analysis reveals combination of KRAS and LRP1B as a predictive biomarker of response to immunotherapy in patients with non-small cell lung cancer.

J Exp Clin Cancer Res · 2025 · PMC11866712 · PMID 40011914

Europe PMC DOI

hedged sentence

0.1320

closest p · 2.6× alpha

0.1320

boldest claim

The sentences

did not reach statistical significancep = 0.132not close (p > 0.1)

8 months, but the difference did not reach statistical significance ( p = 0.132) (Fig. 3 B).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.